Assembly Biosciences Inc
ASMB
Get informed when a big investor buys or sells
+ FollowMarket Cap$409.04M
Close$
$0.18
99.1% downside
Current Fair Value
99.1% downsideOvervalued by 99.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $409.04 Million |
|---|---|
| Enterprise Value | $395.41 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.55 |
| Beta | 1.16 |
| Outstanding Shares | 18,853,646 |
Return
| Return on Equity | -0.01% |
|---|---|
| Return on Assets | -0.01% |
| Return on Invested Capital | -2.92% |
Valuation & Multiples
| P/E Ratio | 36.53 |
|---|---|
| PEG | -58.75 |
| Price to Sales | 10.05 |
| Price to Book Ratio | 1.26 |
| Enterprise Value to Revenue | 9.2 |
| Enterprise Value to EBIT | -44.13 |
| Enterprise Value to Net Income | -9415 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.72
Average shareholder expectationRevenue Estimate
$8.60 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-0.66
Average shareholder expectationRevenue Estimate
$9.07 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6728▲ 67.28% |
|---|---|
| Total Calls | 27,200▲ Infinity% |
| Total Puts | 18,300▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 99.60%▲ 19.32% |
|---|---|
| Total Invested | $515.61M▲ 36.99% |
| Investors Holding | 97▲ 23.00% |
ESG Score
No data